This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Mason, E. O.
Right arrow Articles by Kaplan, S. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, E. O.
Right arrow Articles by Kaplan, S. L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2009, p. 1628-1630, Vol. 47, No. 6
0095-1137/09/$08.00+0     doi:10.1128/JCM.00407-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Vancomycin MICs for Staphylococcus aureus Vary by Detection Method and Have Subtly Increased in a Pediatric Population Since 2005{triangledown}

Edward O. Mason,1,3* Linda B. Lamberth,3 Wendy A. Hammerman,1,3 Kristina G. Hulten,1,3 James Versalovic,2 and Sheldon L. Kaplan1,3

Section of Infectious Diseases, Departments of Pediatrics,1 Pathology, Baylor College of Medicine,2 Infectious Disease Research Laboratory, Texas Children's Hospital, Houston, Texas3

Received 24 February 2009/ Returned for modification 12 April 2009/ Accepted 16 April 2009

Vancomycin MICs for Staphylococcus aureus isolates in a pediatric hospital with a high rate of staphylococcal infections were examined for any increase over a 7-year period. A broth microdilution scheme allowed direct comparison of the MICs generated by this method to MICs generated by Etest. MICs generated by both methods were determined with the same inoculum suspension. One hundred sixty-five S. aureus isolates were selected on the basis of the patients having been bacteremic or having received vancomycin as the definitive therapy for their infections. Of the 165 isolates, 117 were methicillin-resistant S. aureus and 48 were methicillin-susceptible S. aureus. Forty-seven were acquired in the hospital (nosocomial), 56 were community acquired, and 62 were community onset-health care associated. All but one isolate tested by broth microdilution had MICs of <1.0 µg/ml, while 96% of these same isolates tested by Etest had MICs of ≥1 µg/ml. A significant increase in MICs that occurred after study year 4 (2004 to 2005) was demonstrated by the Etest (P < 0.00007) but not by broth microdilution. MICs were not different for isolates of community or health care origin, regardless of methodology. The proportion of isolates with Etest MICs of <1 and ≥1 µg/ml between children with bacteremia for ≤5 days and >5 days (P = 0.3) was not different. We conclude that MICs for pediatric isolates have increased slightly since 2005 and therapeutic decisions based on vancomycin MICs need to be made by considering the methodology used.

* Corresponding author. Mailing address: Pediatric Infectious Diseases FC 1150, Texas Children's Hospital, 6621 Fannin, Houston, TX 77030. Phone: (832) 824-4324. Fax: (832) 825-4347. E-mail: emason{at}bcm.edu

{triangledown} Published ahead of print on 29 April 2009.

Journal of Clinical Microbiology, June 2009, p. 1628-1630, Vol. 47, No. 6
0095-1137/09/$08.00+0     doi:10.1128/JCM.00407-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»